Last month we ran a product demo for a prospective customer. Everything went smoothly. Patient appointment entered, medical history form auto-populated, prescription generated in one click. "Perfect," said the physician. "We want to start immediately."
Two weeks later, during onboarding, they called. "These fields don't exist in our system." "This step works differently for us." "Our doctors don't fill it in this way."
The demo worked. The real world didn't.
This is my story. But it's also a remarkably common one.
According to MIT research, 95% of enterprise generative AI pilots fail to deliver measurable ROI. Say it again: ninety-five percent. Demos look flawless. Production fails.
Why?
Because we designed the demo.
We used clean data. We built a controlled scenario. We sidelined every "what if the user does this" question. We showed the happiest path. The fewest errors. A demo is a product's best day — not its job description.
But the real world doesn't work like that.
In a real clinical software environment, data is messy. One physician enters everything into the system, another only fills in the prescription. One receptionist writes the appointment time five minutes off and the system breaks. One user scrolls to the top of a form, fills it from the middle, then comes back. The AI model is waiting for ideal input. In the real world, ideal doesn't exist.
Is this just a technical problem?
No.
The technical part is actually solvable — data cleaning, edge case handling, fallback mechanisms. The real problem is organizational.
Why do most enterprise AI deployments stumble? Governance gaps. No data policy. Who approves what? Which team owns it? How long does compliance take? These questions don't exist during a demo — because during a demo, there's no real organization. The stage is set, the actors are ready, the audience is impressed. Then the curtain falls. And reality begins.
As PMs, we realize this part too late.
Here's what I've learned: define success before the demo, not during it.
Ask:
- How will we measure what success looks like six months from now?
- What data will enter this system — and what does that data actually look like today?
- When did the person who's going to use this last learn a new tool?
That last question matters. AI products require a learning curve. But the physician who's going to use this sees twenty patients starting at 9 AM. There's no time to learn. Onboarding, habit change, motivation — these have to be part of the product design. Not afterthoughts.
Not "does it work?" but "does it work under real conditions, with real users, under real pressure?"
Demos serve sales, not operations. That's not wrong — sales matter. But as PMs we should also get comfortable being anti-demo: watching how the product behaves under difficult conditions, seeing first real user data in its messy form, discovering that something doesn't work as expected during early adoption — not three months into a signed contract.
Back to the MIT data. 95% failure on measurable ROI means PMs aren't setting success criteria before demos happen. Projects that start with "we'll figure it out as we go" are never measured. Because measurement requires intentional design.
Trying to define success after the fact is like casting a line before you've decided what fish you're catching.
What I do now: before demoing any new feature, I ask one question.
"How do we test this in a way that measures real success — not demo success?"
The answer is usually uncomfortable.
But that discomfort is much cheaper than the production failure that comes later.